Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
18.35
-0.64 (-3.37%)
At close: Jul 10, 2026, 4:00 PM EDT
18.42
+0.07 (0.38%)
After-hours: Jul 10, 2026, 5:43 PM EDT
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $578.49 million as of July 10, 2026. Its market cap has increased by 150.21% in one year.
Market Cap
578.49M
Enterprise Value
553.36M
1-Year Change
150.21%
Ranking
Category
Stock Price
$18.35
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $578.49M, an increase of 897.31%. That is a compound annual growth rate of 68.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 578.49M | 199.13% |
| Dec 31, 2025 | 193.39M | 85.02% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Achieve Life Sciences | 627.25M |
| MiMedx Group | 612.17M |
| Ginkgo Bioworks Holdings | 593.80M |
| Altimmune | 593.15M |
| Crescent Biopharma | 576.19M |
| Eikon Therapeutics | 572.79M |
| Contineum Therapeutics | 567.90M |
| XOMA Royalty | 554.56M |